Technology | January 13, 2011

Emboli, Thrombus Extraction Catheter Cleared by FDA


January 13, 2011 – A catheter that removes emboli and thrombi from vessels in the coronary and peripheral vasculature has received 510(k) clearance from the U.S. Food and Drug Administration. The Xpress-Way RX manual extraction catheter is manufactured by Kaneka Corp. and distributed by Atrium Medical in the United States.

The catheter is an ultra-low profile manual aspiration system designed for the removal of fresh, soft emboli and thrombi in both coronary and peripheral vessels. It incorporates a removable stylet and has been designed with enhanced pushability, anti-kinking, trackability and crossability. Outside the United States, it is marketed as the Thrombuster II.

Thrombus aspiration uses the suction force generated from a syringe to pull soft, fresh thrombus from a vessel. Thrombus can form throughout the body, but manual thrombus aspiration is commonly used in patients who have heart attacks. The main cause of heart attacks is due to a plaque rupture in one of the major coronary arteries, which causes a blood clot to form, reducing blood flow and depriving the heart muscle downstream of oxygen-rich blood. Manual thrombus aspiration is one tool used by interventional cardiologists to remove the blood clot and restore critical blood flow to the heart muscle.

For more information: www.kaneka.co.jp, www.atriummed.com


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now